Sun Pharma to face antitrust trial over Diovan, Nexium, Valcyte Hina Zahid25 Nov 2021 4:34 PM ISTNew Delhi: Sun Pharmaceutical Industries Ltd has lost a bid to avoid facing a trial over allegations that an Indian drug maker it acquired engaged in...
CDSCO panel allows Novartis to waiver conditions for study of anti malarial drug Cipargamin Medical Dialogues Team23 Nov 2021 5:59 PM ISTNew Delhi: Based on the justification provided by the pharma major Novartis, the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Health Bulletin 22/November/2021 Roshni Dhar22 Nov 2021 5:51 PM ISTHere are Top Health stories of the dayPatient dies of Hemorrhagic shock post LSCS: Consumer Court holds medical negligence by doctor, hospital,...
Novartis gets CDSCO panel go ahead for Asciminib Phase 3 trial Roshni Dhar21 Nov 2021 5:18 PM ISTIn a significant development, major drug-maker Novartis has got a go ahead from the Subject Expert Committee (SEC) functional under the Central Drugs...
Novartis gets CDSCO panel nod to study Dabrafenib, Trametinib FDC Medical Dialogues Team21 Nov 2021 11:45 AM ISTNew Delhi: In a significant development, pharma major Novartis has got a go ahead from the Subject Expert Committee (SEC) functional under the Central...
Health Bulletin 20/November/2021 Roshni Dhar20 Nov 2021 4:17 PM ISTHere are Top Health stories of the dayDuty of Medical Council to ensure that doctors do not indulge in offences: Madras HCHolding that it is the duty...
Novartis gets CDSCO panel nod to conduct phase 3 study of anti-cancer drug Asciminib Medical Dialogues Team18 Nov 2021 4:25 PM ISTNew Delhi: In a significant development, major drug-maker Novartis has got a go ahead from the Subject Expert Committee (SEC) functional under the...
Delhi HC restrains 4 pharma firms from making, selling 2 Novartis patent drugs Roshni Dhar10 Nov 2021 12:24 AM ISTIn a major relief to Novartis, the Delhi High Court has restrained various generic pharmaceutical companies from manufacturing or selling Valsartan...
Health Bulletin 8 / November /2021 Roshni Dhar8 Nov 2021 4:53 PM ISTHere are Top Health Stories of the day Patient Dies Post Delivery Due to Heavy Bleeding: Consumer Court Slaps Hospital, Gynecologist, Surgeon with ...
Submit interim safety report: CDSCO panel tells Novartis for phase 3 study of intrathecal OAV-101 Medical Dialogues Team7 Nov 2021 9:30 AM ISTNew Delhi: In a significant development, drug firm Novartis has got a green signal from the Subject Expert Committee (SEC) functional under the...
Novartis cuts uneasy 20-year ties to Roche with USD 20.7 billion voting stake sale Hina Zahid6 Nov 2021 4:01 PM ISTZurich: Novartis AG said on Thursday it would sell its nearly one-third voting stake in Roche back to its cross-town rival for $20.7 billion,...
Novartis, Dunad Therapeutics ink USD 1.3 billion protein degradation deal Ruchika Sharma4 Nov 2021 9:00 AM ISTCambridge: Dunad Therapeutics has recently announced that the company has entered a strategic collaboration and license agreement with Novartis to...
